Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-27
DOI
10.1038/s41598-019-45863-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular vesicles and anti-Cancer drug resistance
- (2018) Niamh Mc Namee et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance
- (2018) Sara Hamis et al. JOURNAL OF THEORETICAL BIOLOGY
- Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
- (2018) Yao Lin et al. Advanced Science
- A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer
- (2018) Grant R. Howard et al. Scientific Reports
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles
- (2017) Priya Samuel et al. PROTEOMICS
- Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
- (2017) Vanessa Lopes-Rodrigues et al. Scientific Reports
- Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells
- (2016) Vanessa Lopes-Rodrigues et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations
- (2016) Tommaso Lorenzi et al. Biology Direct
- Transfer of Drug Resistance Characteristics Between Cancer Cell Subpopulations: A Study Using Simple Mathematical Models
- (2016) María Rosa Durán et al. BULLETIN OF MATHEMATICAL BIOLOGY
- Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces
- (2016) M. C. Lloyd et al. CANCER RESEARCH
- Mathematical Modeling Reveals That Changes to Local Cell Density Dynamically Modulate Baseline Variations in Cell Growth and Drug Response
- (2016) J. M. Greene et al. CANCER RESEARCH
- Transferring intercellular signals and traits between cancer cells: extracellular vesicles as “homing pigeons”
- (2016) Giulia Cesi et al. Cell Communication and Signaling
- An unbiased metric of antiproliferative drug effect in vitro
- (2016) Leonard A Harris et al. NATURE METHODS
- Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
- (2016) Marc Hafner et al. NATURE METHODS
- Dynamics inside the cancer cell attractor reveal cell heterogeneity, limits of stability, and escape
- (2016) Qin Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates
- (2016) Xiaoqiang Sun et al. Scientific Reports
- Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’
- (2015) A O Pisco et al. BRITISH JOURNAL OF CANCER
- Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation
- (2015) R. H. Chisholm et al. CANCER RESEARCH
- In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior
- (2015) Anoek Zomer et al. CELL
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Emerging physiological and pathological implications of tunneling nanotubes formation between cells
- (2015) Sajjad Sisakhtnezhad et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Brain tumour cells interconnect to a functional and resistant network
- (2015) Matthias Osswald et al. NATURE
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors
- (2015) Monika A. Davare et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles
- (2015) Diana Sousa et al. TRENDS IN MOLECULAR MEDICINE
- Spatial Heterogeneity in Drug Concentrations Can Facilitate the Emergence of Resistance to Cancer Therapy
- (2015) Feng Fu et al. PLoS Computational Biology
- Resistance to Chemotherapy: Patient Variability and Cellular Heterogeneity
- (2014) David A. Kessler et al. CANCER RESEARCH
- Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
- (2014) Mirjam C. Boelens et al. CELL
- EdgeMarker: Identifying differentially correlated molecule pairs as edge-biomarkers
- (2014) Wanwei Zhang et al. JOURNAL OF THEORETICAL BIOLOGY
- A multi-phenotypic cancer model with cell plasticity
- (2014) Da Zhou et al. JOURNAL OF THEORETICAL BIOLOGY
- Evolution of acquired resistance to anti-cancer therapy
- (2014) Jasmine Foo et al. JOURNAL OF THEORETICAL BIOLOGY
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- What do drug transporters really do?
- (2014) Sanjay K. Nigam NATURE REVIEWS DRUG DISCOVERY
- Simplifying the complexity of resistance heterogeneity in metastasis
- (2014) Orit Lavi et al. TRENDS IN MOLECULAR MEDICINE
- The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance
- (2013) O. Lavi et al. CANCER RESEARCH
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance
- (2013) Edwin Wang et al. SEMINARS IN CANCER BIOLOGY
- Non-Darwinian dynamics in therapy-induced cancer drug resistance
- (2013) Angela Oliveira Pisco et al. Nature Communications
- Overcoming mutation-based resistance to antiandrogens with rational drug design
- (2013) Minna D Balbas et al. eLife
- Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: Incorporating EGFR signaling pathway and angiogenesis
- (2012) Xiaoqiang Sun et al. BMC BIOINFORMATICS
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model
- (2011) Jennifer Pasquier et al. Biology Direct
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Gene Expression Noise Facilitates Adaptation and Drug Resistance Independently of Mutation
- (2011) Daniel A. Charlebois et al. PHYSICAL REVIEW LETTERS
- How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
- (2010) M Gerlinger et al. BRITISH JOURNAL OF CANCER
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells
- (2009) M Bebawy et al. LEUKEMIA
- ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
- (2008) N. BELLOMO et al. MATHEMATICAL MODELS & METHODS IN APPLIED SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started